Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Mar 03, 2025
Contract Type
partnership
Description
Novo Holdings and TA Associates have entered into a partnership agreement to invest in Biocomposites, an international medical devices company specializing in products for infection management. The additional investment and resources aim to accelerate Biocomposites' international expansion and innovation in infection management products.
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Biocomposites signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.